These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10438324)

  • 1. Up-regulation of tumor necrosis factor alpha mRNA is associated with bovine-leukemia virus (BLV) elimination in the early phase of infection.
    Kabeya H; Ohashi K; Oyunbileg N; Nagaoka Y; Aida Y; Sugimoto C; Yokomizo Y; Onuma M
    Vet Immunol Immunopathol; 1999 May; 68(2-4):255-65. PubMed ID: 10438324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of bovine leukemia virus (BLV)-specific lymphocyte proliferation responses in ruminants by inoculation with BLV env-recombinant vaccinia virus: their role in the suppression of BLV replication.
    Ohishi K; Suzuki H; Yasutomi Y; Onuma M; Okada K; Numakunai S; Ohshima K; Ikawa Y; Sugimoto M
    Microbiol Immunol; 1992; 36(12):1317-23. PubMed ID: 1337572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant viral vaccines for enzootic bovine leucosis.
    Daniel RC; Gatei MH; Good MF; Boyle DB; Lavin MF
    Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():399-404. PubMed ID: 8270269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes.
    Cherney TM; Schultz RD
    Am J Vet Res; 1996 Jun; 57(6):812-8. PubMed ID: 8725805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha and its receptors in experimentally bovine leukemia virus-infected sheep.
    Kabeya H; Fukuda A; Ohashi K; Sugimoto C; Onuma M
    Vet Immunol Immunopathol; 2001 Aug; 81(1-2):129-39. PubMed ID: 11498252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferating cell nuclear antigen expression in sheep infected with bovine leukemia virus.
    Hailata N; Johnson R; al-Bagdadi F; Hanash S
    Vet Immunol Immunopathol; 1995 Feb; 44(3-4):211-22. PubMed ID: 7747402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep.
    Kabeya H; Ohashi K; Ohishi K; Sugimoto C; Amanuma H; Onuma M
    Vaccine; 1996 Aug; 14(12):1118-22. PubMed ID: 8911007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine TNF-α and its receptors TNFRI and TNFRII play a key role in the in vitro proliferative response of BLV infected animals.
    Lendez PA; Martinez-Cuesta L; Nieto Farias MV; Dolcini GL; Ceriani MC
    Vet Res Commun; 2021 Dec; 45(4):431-439. PubMed ID: 34453235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovine MHC class II DRB1 alleles associated with resistance or susceptibility to development of bovine leukemia virus-induced ovine lymphoma.
    Nagaoka Y; Kabeya H; Onuma M; Kasai N; Okada K; Aida Y
    Cancer Res; 1999 Feb; 59(4):975-81. PubMed ID: 10029093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term protection against bovine leukaemia virus replication in cattle and sheep.
    Kerkhofs P; Gatot JS; Knapen K; Mammerickx M; Burny A; Portetelle D; Willems L; Kettmann R
    J Gen Virol; 2000 Apr; 81(Pt 4):957-63. PubMed ID: 10725421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of CD8+ T cells in delayed-type hypersensitivity responses against bovine leukemia virus (BLV) induced in sheep vaccinated with recombinant vaccinia virus expressing BLV envelope glycoprotein.
    Okada K; Ikeyama S; Ohishi K; Suzuki H; Sugimoto M; Numakunai S; Chiba T; Murakami K; Davis WC; Ohshima K
    Vet Pathol; 1993 Mar; 30(2):104-10. PubMed ID: 8470333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma expression associated with suppression of bovine leukemia virus at the early phase of infection in sheep.
    Usui T; Konnai S; Ohashi K; Onuma M
    Vet Immunol Immunopathol; 2007 Jan; 115(1-2):17-23. PubMed ID: 17064782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulative effects of bovine immunodeficiency-like virus (BIV)-infection and mixed infection of BIV and bovine leukemia virus on sheep.
    Hirai N; Kabeya H; Ohashi K; Sugimoto C; Onuma M
    Jpn J Vet Res; 1996 Dec; 44(3):153-63. PubMed ID: 8997876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination of bovine leukemia virus-infected cells from a newly infected sheep lymph node.
    Fulton BE; Portella M; Radke K
    J Virol; 2006 Aug; 80(16):7873-84. PubMed ID: 16873244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
    Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
    J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed emergence of bovine leukemia virus after vaccination with a protective cytotoxic T cell-based vaccine.
    Mateo L; Gardner J; Suhrbier A
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1447-53. PubMed ID: 11679157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell dynamics and immune response to BLV infection: a unifying model.
    Florins A; Gillet N; Asquith B; Boxus M; Burteau C; Twizere JC; Urbain P; Vandermeers F; Debacq C; Sanchez-Alcaraz MT; Schwartz-Cornil I; Kerkhofs P; Jean G; Théwis A; Hay J; Mortreux F; Wattel E; Reichert M; Burny A; Kettmann R; Bangham C; Willems L
    Front Biosci; 2007 Jan; 12():1520-31. PubMed ID: 17127399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cell-mediated immunity in bovine leukemia virus (BLV) infection in ruminants: its implication for the vaccination strategy against retroviruses.
    Sugimoto M; Ohishi K; Ikawa Y
    Ther Immunol; 1994 Oct; 1(5):297-301. PubMed ID: 7584504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of vaccination with bovine leukemia virus (BLV) Tax DNA against BLV infection in sheep.
    Usui T; Konnai S; Tajima S; Watarai S; Aida Y; Ohashi K; Onuma M
    J Vet Med Sci; 2003 Nov; 65(11):1201-5. PubMed ID: 14665749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell proliferative response to bovine leukaemia virus (BLV): identification of T cell epitopes on the major core protein (p24) in BLV-infected cattle with normal haematological values.
    Mager A; Masengo R; Mammerickx M; Letesson JJ
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2223-31. PubMed ID: 7521391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.